Evidence map›Paper›PMID 42204595›Full record

ArticleTropical medicine and health2026

Efficacy and cost-effectiveness of outdoor residual spraying with α-cypermethrin, pirimiphos-methyl, and deltamethrin against sand flies: a pragmatic cluster randomised controlled field trial in Uganda.

Kamoga Livingstone, Edwin Kigozi, Nelson Ssewante, Blaise Kiyimba, Shamim Nabidda, Elvis Seremba, Andrew Munerya, Richard Achuma, Damiano Lomokol, Nantume Olivia and 6 more

Abstract read
In one paragraph

Article in Tropical medicine and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Kamoga LivingstoneDepartment of Nursing, College of Health Sciences, Makerere University, Kampala, Uganda. kamogastone27@gmail.com.ORCID http://orcid.org/0000-0002-7822-4245
Edwin KigoziDepartment of Nursing, College of Health Sciences, Makerere University, Kampala, Uganda.
Nelson SsewanteChild Health and Development Centre, College of Health Sciences, Makerere University, Kampala, Uganda.
Blaise KiyimbaDepartment of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
Shamim NabiddaDepartment of Nursing and Midwifery, Aga Khan University, Kampala, Uganda.
Elvis SerembaDepartment of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
Andrew MuneryaAmudat Church of Uganda Hospital, Amudat District Local Government, Amudat, Uganda.
Richard AchumaAmudat Church of Uganda Hospital, Amudat District Local Government, Amudat, Uganda.
Damiano LomokolAmudat Church of Uganda Hospital, Amudat District Local Government, Amudat, Uganda.
Nantume OliviaDepartment of Pharmacy, Kampala School of Paramedicals, Kayunga, Uganda.
Patrick Banadda MatovuDepartment of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
Daniel TamaleDepartment of Nursing, College of Health Sciences, Makerere University, Kampala, Uganda.
Patrick SagakiAmudat Church of Uganda Hospital, Amudat District Local Government, Amudat, Uganda.
Joshua EpuitaiDepartment of Nursing, Busitema University, Mbale, Uganda.
Felix BongominDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Gulu University, Gulu, Uganda.
Scovia Nalugo MbalindaDepartment of Nursing, College of Health Sciences, Makerere University, Kampala, Uganda.

Funding

Children's Investment Fund Foundation CIFF2448Royal Society of Tropical Medicine and Hygiene CIFF2448
6 · The paper itself

Abstract

introductionVisceral leishmaniasis (VL) is a significant public health challenge in East Africa. Achieving the WHO 2030 target of reducing VL mortality to below 1% requires novel control strategies. In this study, we evaluated the efficacy and cost-effectiveness of three insecticide formulations for outdoor residual insecticide spraying (ORS) in selected villages of Amudat district, Uganda.

methodsA pragmatic clustered randomised controlled field trial was conducted in five clusters. Three clusters were randomly allocated to receive ORS with either α-cypermethrin, pirimiphos-methyl, or deltamethrin, while two clusters served as untreated controls. The primary outcome was the change in sandfly counts per trap-night, measured using CDC light and sticky traps before and after the intervention. These were compared using the Wilcoxon signed-rank test to assess reductions independent of other villages. Then, we used negative binomial regression with a log link of trap-nights to model sandfly counts, which were included as an offset to account for variation in sampling effort.

resultsAfter spraying the insecticides in the intervention villages, the sandfly population declined by 62%, 60%, and 49% with α-cypermethrin, pirimiphos-methyl, and deltamethrin, respectively. Sandfly captures increased by fourfold (353%) in the control villages in the same period. Using a negative binomial regression with village-clustered standard errors, α-cypermethrin reduced sandfly counts by 92% compared to the change in control villages (IRR = 0.08, 95% CI 0.07-0.38, p < 0.001). Pirimiphos-methyl and deltamethrin reduced counts by 91% (IRR = 0.09, 95% CI 0.07-0.45) and 89% (IRR = 0.11, 95% CI 0.10-0.56), respectively. A cost-effectiveness analysis showed that α-cypermethrin emerged as a more cost-effective option, followed by deltamethrin and lastly pirimiphos-methyl, with annual cost per village of $382, $390 and $408, respectively.

conclusionOur findings provide tentative observations that may guide vector control programmes. The relatively high efficacy and favourable cost-effectiveness of α-cypermethrin are suggestive that it could be a suitable option for inclusion in integrated vector management strategies targeting outdoor sandfly populations in this region.

Indexed as

AmudatEast AfricaInsecticidesKala AzarVisceral leishmaniasis

Identifiers

PMID42204595
PMCPMC13217796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.